Page last updated: 2024-11-12

adonixanthin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

adonixanthin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

adonixanthin : A carotenone that consists of beta,beta-caroten-4-one bearing two hydroxy substituents at positions 3 and 3' (the 3S,3'R diastereomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16061189
CHEBI ID80217
SCHEMBL ID14519499
MeSH IDM0534351

Synonyms (28)

Synonym
adonixanthin/ 4-ketozeaxanthin
LMPR01070016
3,3'-dihydroxy-beta,beta-carotene-4-one
adonixanthin
4-ketozeaxanthin
3,3'-dihydroxy-4-keto-beta,beta-carotene
SCHEMBL14519499
(3s,3'r)-adonixanthin
(3s,3'r)-3,3'-dihydroxy-beta,beta-caroten-4-one
doradexanthin
all-trans-beta-doradexanthin
CHEBI:80217
all-trans-adonixanthin
(3s,3'r)-dihydroxy-4-keto-beta,beta-carotene
.beta.-doradexanthin
PSZ3Q7662U ,
(3s,3'r)-4-keto-zeaxanthin
3,3'-dihydroxyechinenone
beta-caroten-4-one, 3,3'-dihydroxy-
unii-psz3q7662u
all-trans-.beta.-doradexanthin
4-keto-zeaxanthin
.beta.,.beta.-caroten-4-one, 3,3'-dihydroxy-, (3s,3'r)-
beta,beta-caroten-4-one, 3,3'-dihydroxy-, (3s,3'r)-
(3s,3'r)-3,3'-dihydroxy-.beta.,.beta.-caroten-4-one
.beta.-caroten-4-one, 3,3'-dihydroxy-
beta-doradexanthin
Q27149334
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (6)

RoleDescription
algal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in algae including unicellular organisms like chlorella and diatoms to multicellular organisms like giant kelps and brown algae.
animal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals.
marine metaboliteAny metabolite produced during a metabolic reaction in marine macro- and microorganisms.
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
cyclic ketone
secondary alcoholA secondary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has two other carbon atoms attached to it.
carotenone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
astaxanthin biosynthesis (bacteria, fungi, algae)413
2,2'-dihydroxyketocarotenoids biosynthesis214
astaxanthin biosynthesis (bacteria, fungi, algae)513

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's6 (60.00)24.3611
2020's3 (30.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.73 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index5.55 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]